Home   >  
Angiogenesis/Protein Tyrosine Kinase
  >  
HIF
  >   JNJ-42041935
JNJ-42041935 Chemical Structure

JNJ-42041935

Data Sheet For research use only. Not for human use.
Cat. No. :BCP16311CAS No. :1193383-09-3Purity:98%
 Tel: 0086-17754423994   or   orders@biochempartner.com
Real-Time Inquiry ×

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • Chemical Properties&Biological Activity
CAS No. 1193383-09-3 Cat. No. BCP16311
Name JNJ-42041935
Synonyms JNJ 42041935;JNJ42041935;
SMILES
Chemical Name
Formula C12H6ClF3N4O3 M. Wt 346.65
Purity 98% Storage Store at 4-8°C
Description in vitro: JNJ-42041935 was the most potent inhibitor of PHD2181–417 with a pIC50 value of 7.0 ± 0.03. JNJ-42041935 also inhibited full-length PHD1, PHD2, and PHD3 enzymes (pKI values = 7.91 ± 0.04, 7.29 ± 0.05, and 7.65 ± 0.09, respectively). JNJ-42041935 was highly selective for PHD relative to FIH (pIC50~4). JNJ-42041935 and desferrioxamine were approximately equipotent in the HIF-1α accumulation and erythropoietin secretion assays in Hep3B cells . in vivo: Administration of JNJ-42041935 (100 μmol/kg p.o.) for 5 consecutive days resulted in a 2-fold increase in reticulocytes, an increase in hemoglobin by 2.3 g/dl, and an increase in the hematocrit of 9%. Two hours after oral administration of 300 μmol/kg JNJ-42041935, the bioluminescence over the peritoneal area was increased by 2.2 ± 0.3-fold relative to luciferase-treated vehicle controls in the mouse .
  • Quality Control&Technical Support
In the process of purchasing and using Biochempartner products, you can consult us if you have any problems: orders@biochempartner.com. We will try our best to solve all your doubts.

Recommend Products

More >

Tags:JNJ-42041935 supplier,JNJ-42041935 purchase,JNJ-42041935 manufacturer,JNJ-42041935 distributor,JNJ-42041935 cost,JNJ-42041935 buy,JNJ-42041935 for sale

0086-13720134139